Infinity Pharmaceuticals (INFIQ) 10-Q2004 Q1 Quarterly report

Filed: 7 May 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: abandoned, Absent, accretive, alerting, assist, attain, attempting, aware, began, begun, biopharmaceutical, breach, category, claim, Code, complementary, compromised, consideration, Delaware, delivery, deterred, disadvantaged, divest, divestiture, efficient, enhancing, Food, formalized, found, founded, heavily, imaging, imbalance, important, incubation, interference, isotopic, launch, LLC, long, low, marketplace, milestone, mix, notwithstanding, originally, proceeding, processed, promising, quantified, radio, reincorporated, reliable, selecting, shut, shutting, SIDDCO, simultaneously, subcontractor, succeeding, tax, taxable, throughput, treasury, trial, type, uncured, warranty

Removed: accrual, acid, adjustment, adversely, affecting, Affymetrix, Albany, alternative, amendment, amount, analyst, analyzed, appealed, Argonaut, ArQule, Array, assumed, assurance, Biopharma, bring, cease, Cerep, collected, communicated, converted, delivering, determining, direct, discovered, diverse, dividend, EITF, enforcing, entity, essentially, Evotec, exercisable, FASB, fewer, fifty, financed, full, good, hand, hexane, hydrochloric, hydroxide, identified, imperative, initiated, involving, isolated, Issue, June, junior, Kussman, Logic, longer, methanol, Molecular, motivating, OAI, occur, participating, percent, periodically, permanganate, permit, person, Pharmacopeia, popularity, potassium, preferred, prevail, producing, Program, proposed, prospectively, purified, recover, recoverability, redeemed, redeployment, reduced, reducing, request, resolved, ROI, satisfy, saturate, saturated, shift, significance, sodium, solicit, sustain, targeted, tetrahydrofuran, transition, transitioning, triethylamine, trifluoroacetic, unit, unprofitable, voluntarily

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

INFIQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Discovery Partners International, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Riccardo Pigliucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report.

/s/ Riccardo Pigliucci
Riccardo Pigliucci
Chief Executive Officer


Date: May 7, 2004